/SWAV

SWAV Stock - ShockWave Medical, Inc.

Q: What is the analyst price target for SWAV?

Analyst price target information is not currently available for SWAV.

Q: What is SWAV's market cap?

Market capitalization information is not currently available for SWAV.

Healthcare|Medical - Devices|NASDAQ

$334.75-0.02%

$0.08 (-0.02%) • May 30

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+-26.0%upside

Target: $247.72

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SWAV

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.88

52W High$334.90

52W Low$157.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$730.23M	$489.73M	$237.15M	$67.79M	$42.93M
Gross Profit	$634.84M	$424.74M	$195.71M	$46.80M	$25.77M
Gross Margin	86.9%	86.7%	82.5%	69.0%	60.0%
Operating Income	$165.99M	$124.13M	$-871,000	$-65,663,000	$-51,839,000
Net Income	$147.28M	$216.00M	$-9,136,000	$-65,699,000	$-51,109,000
Net Margin	20.2%	44.1%	-3.9%	-96.9%	-119.1%
EPS	$4.01	$6.02	$-0.26	$-1.99	$-2.14

Company Overview

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

50%

Hold / Neutral

38%

Sell / Underperform

13%

Analyst Consensus🟡 Mixed

4 Bullish4 Neutral/Bearish

Price Targets

$266

Average Target

↓ 20.6% Downside

Now

$165

Low

$266

Average

$368

High

Based on 9 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
April 5th 2024	Wolfe Research	Downgrade	Peer Perform	-
March 27th 2024	CL King	Initiation	Buy	$368
September 29th 2023	UBS	Initiation	Neutral	$218
July 10th 2023	Morgan Stanley	Upgrade	Overweight	$335← $291
May 30th 2023	Morgan Stanley	Resumed	Equal Weight	$291
March 15th 2023	Needham	Initiation	Buy	$240
December 16th 2022	Deutsche Bank	Initiation	Buy	$285
December 12th 2022	Wells Fargo	Downgrade	Equal Weight	$235← $300
September 6th 2022	Oppenheimer	Downgrade	Underperform	$165
April 6th 2022	Wolfe Research	Initiation	Outperform	$255

Earnings History & Surprises

SWAV

Beat Rate

80%

Last 20 quarters

Avg Surprise

+57.0%

EPS vs Estimate

Beats / Misses

16/4

Last 12 quarters

Latest EPS

$1.44

Q2 2024

EPS Surprise History

Q3 22

+54.5%

$0.68vs$0.44

Q4 22

+37.3%

$0.92vs$0.67

Q1 23

+274.7%

$3.71vs$0.99

Q2 23

+27.2%

$1.03vs$0.81

Q3 23

-11.6%

$0.76vs$0.86

Q4 23

+16.5%

$0.92vs$0.79

Q1 24

+30.3%

$1.16vs$0.89

Q2 24

+46.9%

$1.44vs$0.98

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2024	May 6, 2024	$0.98	$1.44	+46.9%	✓ BEAT
Q1 2024	Feb 15, 2024	$0.89	$1.16	+30.3%	✓ BEAT
Q4 2023	Nov 6, 2023	$0.79	$0.92	+16.5%	✓ BEAT
Q3 2023	Aug 7, 2023	$0.86	$0.76	-11.6%	✗ MISS
Q2 2023	May 8, 2023	$0.81	$1.03	+27.2%	✓ BEAT
Q1 2023	Feb 16, 2023	$0.99	$3.71	+274.7%	✓ BEAT
Q4 2022	Nov 7, 2022	$0.67	$0.92	+37.3%	✓ BEAT
Q3 2022	Aug 8, 2022	$0.44	$0.68	+54.5%	✓ BEAT
Q2 2022	May 9, 2022	$0.18	$0.39	+116.7%	✓ BEAT
Q1 2022	Feb 17, 2022	$0.09	$0.34	+277.8%	✓ BEAT
Q4 2021	Nov 8, 2021	$-0.06	$0.05	+183.3%	✓ BEAT
Q3 2021	Aug 9, 2021	$-0.41	$-0.01	+97.6%	✓ BEAT
Q2 2021	May 10, 2021	$-0.42	$-0.68	-61.9%	✗ MISS
Q1 2021	Feb 17, 2021	$-0.41	$-0.46	-12.2%	✗ MISS
Q4 2020	Nov 9, 2020	$-0.55	$-0.38	+30.9%	✓ BEAT
Q3 2020	Aug 11, 2020	$-0.66	$-0.56	+15.2%	✓ BEAT
Q2 2020	May 12, 2020	$-0.48	$-0.59	-22.9%	✗ MISS
Q1 2020	Feb 13, 2020	$-0.50	$-0.49	+2.0%	✓ BEAT
Q4 2019	Nov 7, 2019	$-0.49	$-0.46	+6.1%	✓ BEAT
Q3 2019	Aug 5, 2019	$-0.55	$-0.38	+30.9%	✓ BEAT

Frequently Asked Questions about SWAV

What is SWAV's current stock price?

ShockWave Medical, Inc. (SWAV) is currently trading at $334.75 per share. The stock has moved -0.02% today.

What is the analyst price target for SWAV?

The average analyst price target for SWAV is $247.85, based on 1 analyst.

What sector is ShockWave Medical, Inc. in?

ShockWave Medical, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is SWAV's market cap?

ShockWave Medical, Inc. has a market capitalization of $12.57 billion, making it a large-cap company.

Does SWAV pay dividends?

No, ShockWave Medical, Inc. does not currently pay a dividend to shareholders.